Health ❯ Healthcare ❯ Clinical Research

Drug Approval

FDA FDA Regulations Generic Medications Lecanemab in Germany Anvisa FDA Approval EU Regulations FDA and EMA FDA and EMA Regulations NICE Guidelines

Anvisa Expands Wegovy and Ozempic Uses to Cardiovascular and Kidney Protection

Regulators cited trial evidence that semaglutide reduces major cardiac events independent of weight loss.

IQWiG Says Leqembi Shows No Added Benefit for Early Alzheimer’s Patients

Intranasal Epinephrine Nears AIFA Sign-Off, Italian Launch Targeted for 2026

Leqembi Launches in Germany for Early Alzheimer’s Patients

One in Three Infants Received Preventive RSV Antibody in First Season, Study Finds

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention